Skip to main content

Table 3 Comparison of laboratory measures between the two improved and non-improved groups undergoing the study intervention

From: Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)

Variable Improved patients (N = 6) Non-improved patients (N = 4) p-value (t-test)
Mean age (year) 55.33 ± 21.38 60.25 ± 14.10 0.699
Baseline white blood cell count (×  109/L) 8900.00 ± 3204.99 15,225.00 ± 7125.71 0.088
Baseline percentage of plasma lymphocytes (%) 8.90 ± 3.58 3.48 ± 1.96 0.038
Serum hemoglobin (mg/dL) 11.05 ± 1.69 11.30 ± 1.80 0.829
Serum platelet count (× 109/L) 241,833.33 ± 139,053.11 236,250.00 ± 78,415.03 0.944
Serum c-reactive protein (mg/L) 152.00 ± 100.07 110.00 ± 56.93 0.538
Serum lactate dehydrogenase (U/L) 819.67 ± 116.17 1400.00 ± 353.55 0.066
Blood urea nitrogen (mg/dL) 30.50 ± 22.16 51.50 ± 36.35 0.284
Serum creatinine (mg/dL) 1.23 ± 0.88 1.90 ± 1.65 0.425
Serum aspartate aminotransferase (SGOT) (U/L) 68.00 ± 26.00 41.75 ± 13.91 0.141
Serum alanine aminotransferase (SGPT) (U/L) 52.00 ± 19.97 28.25 ± 8.96 0.083
Serum IL-6 (ng/mL) 122.83 ± 76.49 165.00 ± 149.29 0.568*
  1. *Mann-Whitney test
\